Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2009 by Dana-Farber Cancer Institute.
Recruitment status was Active, not recruiting

Sponsor:

Collaborators:

Brigham and Women's Hospital

Massachusetts General Hospital

AstraZeneca

Information provided by:

Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:

NCT00165308

First received: September 9, 2005

Last updated: October 30, 2009

Last verified: October 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2010
Primary Completion Date:	May 2003 (Final data collection date for primary outcome measure)